Skip to content

Packing of Perianal Abscess Cavities

The Impact of Postoperative Packing of Perianal Abscess Cavities: a Multicentre Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03315169
Acronym
PPAC2
Enrollment
433
Registered
2017-10-20
Start date
2018-02-14
Completion date
2020-06-12
Last updated
2020-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abscess Anorectal, Abscess; Anus, Perianal Abscess, Perianal Infections, Peri Rectal Abscess

Keywords

Incision and Drainage, Packing

Brief summary

The aim of this trial is to compare internal wound packing to no packing in postoperative management following incision and drainage of perianal abscess. Participants will be randomised 1:1 to either the packing or non-packing arm.

Detailed description

Perianal abscess is common, affecting 18,000 patients annually in England. Management has remained largely unchanged for over 50 years, and comprises surgical incision and drainage followed by continued internal wound dressing (packing) until healed. Packing is thought to reduce the rate of recurrent abscess and perianal fistula; a known complication of perianal abscess. Perianal fistula frequently requires multiple operations to resolve. The evidence for postoperative packing is limited¹ and may expose patients to painful procedures with no clinical benefit, and at considerable increased cost². A multi-centre observational study of outcomes after drainage of perianal abscess (PPAC²) (n=141) found packing to be painful (2-3 fold increase in Visual Analogue Score pain scores during packing) and costly (estimated cost of £280 per patient; overall cost in the United Kingdom of £5 million annually). Fistula rate was 27%. This study is a randomised controlled trial designed to assess whether there are differences between non-packing and packing of the perianal abscess cavity in terms of the short term negative effects of packing (pain, quality of life, return to work) whilst assessing the impact on key clinical outcomes (wound healing, fistulae formation) and resource use/cost. All participants will be required to complete pain diaries following discharge from hospital. Clinical follow up to assess healing and other key clinical outcomes will take place at 4, 8 (if not healed at 4 weeks) and 26 weeks. Further data will be collected from National Health Service Registries at 52 weeks in order to assess abscess recurrences and fistulae formation.

Interventions

Application of external dressing whilst perianal abscess cavity heals.

OTHERPacking of perianal abscess cavity

Internal packing of perianal abscess cavity - standard treatment.

Sponsors

University of Liverpool
CollaboratorOTHER
Northwest Research Collaborative
CollaboratorUNKNOWN
University of Birmingham
CollaboratorOTHER
National Institute for Health Research, United Kingdom
CollaboratorOTHER_GOV
Manchester University NHS Foundation Trust
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Note that only the clinician assessing healing and fistulae are masked.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Aged 18 or over 2. Undergoing surgical incision and drainage of a primary perianal abscess

Exclusion criteria

1. Suspected inflammatory bowel disease 2. Fournier's Gangrene 3. Horseshoe (bilateral) abscess 4. Fistula-in-ano 5. Multiple abscess

Design outcomes

Primary

MeasureTime frameDescription
Wound-related pain intensityMean score over first 10 post-operative daysWound-related pain intensity (worst pain during previous 24 hours) measured using a single 100mm Visual Analogue Scale where 0 represents 'no pain' and 100 represents 'worst pain possible'. The pain Visual Analogue Scale is a continuous scale comprised of a horizontal line 100mm in length, anchored by 2 verbal descriptors, one for each symptom extreme, where 0 represents 'no pain' and 100 represents 'worst pain possible'. The mean score over the first 10 post-operative days will be used.

Secondary

MeasureTime frameDescription
Health related quality of lifeOn the 21st post-operative dayHealth related quality of life measured using EuroQol EQ-5D-5L quality of life questionnaires. The EQ-5D-5L descriptive system comprises 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension now has 5 levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. The respondent is asked to indicate his/her health state by ticking (or placing a cross) in the box against the most appropriate statement in each of the 5 dimensions. This decision results in a 1-digit number expressing the level selected for that dimension. The digits for 5 dimensions can be combined in a 5-digit number describing the respondent's health state.
Health utilityOn the 21st post-operative dayHealth utility measured using EuroQol EQ-5D-5L quality of life questionnaires. The EQ-5D-5L descriptive system comprises 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension now has 5 levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. The respondent is asked to indicate his/her health state by ticking (or placing a cross) in the box against the most appropriate statement in each of the 5 dimensions. This decision results in a 1-digit number expressing the level selected for that dimension. The digits for 5 dimensions can be combined in a 5-digit number describing the respondent's health state.
Patient satisfaction with wound managementOn the 21st post-operative dayPatient satisfaction with wound management measured using a five point Likert scale. Patients are asked to mark the extent to which they agree with the statement 'I am satisfied with the way my wound has been treated following my surgery' where 1 equates to 'strongly disagree' and 5 equates to 'strongly agree'.
Rate of wound healingFour and eight weeks post-operativelyRate of wound healing (complete epithelialization)
Clinical diagnosis of perianal abscesses recurrence after healing52 weeks post-operativelyClinical diagnosis of perianal abscesses recurrence after healing, ascertained either through clinical follow-up as part of trial procedures or via central National Health Service registries.
Chronic post-surgical pain4, 8 and 26 weeks post-operativelyChronic post-surgical pain measured using the Brief Pain Inventory - Short Form. The Brief Pain Inventory - Short Form assesses the severity of pain and the impact on daily functions. Pain is assessed at its worst, least, average, and now (current pain), measured on a scale of 1-10 where 1 represents no pain and 10 represents pain as bad as you can imagine. The four items will be represented singly but a composite of the four pain items (a mean score) will be presented as supplemental information. Pain interference (impact of pain on seven daily activities) will be scored as the mean of the seven interference items. These items are scored between 1 and 10, where 1 represents does not interfere and 10 represents completely interferes.
Dressing-change related pain intensityFirst 10 post-operative daysPain before, during and after dressing change measured using a 100mm Visual Analogue Scale where 0 represents 'no pain' and 100 represents 'worst pain possible'. The pain Visual Analogue Scale is a continuous scale comprised of a horizontal line 100 mm in length, anchored by 2 verbal descriptors, one for each symptom extreme. The mean score for each timepoint (before, during and after) over the first 10 post-operative days will be used.
Health Professional contact timeUp to 52 weeks post-operativelyNumber of contacts with a Health Professional regarding perianal abscess or post-surgical complications between time of operation and 52 weeks post-operatively.
Hospital admission timeUp to 52 weeks post-operativelyNumber and length of hospital admissions as recorded in NHS central registries - Hospital Episodes Statistics.
Time to return to work or normal functionUp to 52 weeks post-operativelyLength of time, measured in days, between operation and return to work or normal function.
CostUp to 52 weeks post-operativelyCost as applied to resource use data (see outcome 9-12)
Assessment of pain control methods21 days post-operativelyAssessment of pain control methods (i.e. pain control medications) using Patient Global Assessment of the method of pain control where a rating of the pain control method over the past 24 hours is rated as being one of poor, fair, good, or excellent.
Fistula rateUp ro 52 weeks post-operativelyFistula rate observed during clinical follow up and through Hospital Episodes Statistics
Dressing useUp to 52 weeks post-operativelyNumber of dressings used between time of operation up until week 52.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026